» Articles » PMID: 39841292

Suppression of Chemically Induced Mammary Cancer by Early-life Oral Administration of Cholera Toxin in Mice is Associated with Aberrant Regulation of Bmp and Notch Signaling Pathways

Overview
Journal Mol Biol Rep
Date 2025 Jan 22
PMID 39841292
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lately, significant attention has been drawn towards the potential efficacy of cholera toxin (CT)-an exotoxin produced by the small intestine pathogenic bacterium Vibrio cholera-in modulating cancer-promoting events. In a recent study, we demonstrated that early-life oral administration of non-pathogenic doses of CT in mice suppressed chemically-induced carcinogenesis in tissues distantly located from the gut. In the mammary gland, CT pretreatment was shown to reduce tumor multiplicity, increase apoptosis and alter the expression of several cancer-related molecules. In the present work we investigated the protumorigenic mammary microenvironment for possible associations between early life CT administration and the expression of key components of the Bmp and Notch signaling pathways.

Methods And Results: Total RNA from mammary tissue samples were retrieved from a recent experiment where FVB/N female mice were preconditioned with CT and later treated with the carcinogen 7,12-dimethylbenzanthracene (DMBA). Real-time PCR was used for relative quantification of gene expression. Our results revealed that CT anti-tumor effects significantly correlated with deregulation of crucial BMP pathway elements, with downregulation of Bmp7 ligand and upregulation of inhibitory Smad6 being the most prominent alterations observed. Concerning Notch signaling pathway, significantly elevated gene expression levels in the CT-treated DMBA mice, as compared to their non-treated counterparts, were also identified at the ligand-receptor level.

Conclusions: These findings suggest that CT tumor protective effects in the mammary gland are associated with discerning deregulation of components of both Bmp and Notch signaling pathways and provide insights into the mechanisms underlying CT's anti-cancer outcome.

References
1.
Erdman S, Poutahidis T . Cancer inflammation and regulatory T cells. Int J Cancer. 2010; 127(4):768-79. PMC: 4068033. DOI: 10.1002/ijc.25430. View

2.
Poutahidis T, Kleinewietfeld M, Erdman S . Gut microbiota and the paradox of cancer immunotherapy. Front Immunol. 2014; 5:157. PMC: 3985000. DOI: 10.3389/fimmu.2014.00157. View

3.
Poutahidis T, Angelopoulou K, Erdman S . Old enemies meet new friends for colon cancer prevention. Oncoimmunology. 2015; 4(10):e1027474. PMC: 4589059. DOI: 10.1080/2162402X.2015.1027474. View

4.
Erdman S, Poutahidis T . Microbes and Oxytocin: Benefits for Host Physiology and Behavior. Int Rev Neurobiol. 2016; 131:91-126. DOI: 10.1016/bs.irn.2016.07.004. View

5.
Lakritz J, Poutahidis T, Levkovich T, Varian B, Ibrahim Y, Chatzigiagkos A . Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. Int J Cancer. 2014; 135(3):529-40. PMC: 4131439. DOI: 10.1002/ijc.28702. View